問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number100CRS02(Toray Industries, Inc)/533-CL-003(Astellas Pharma Inc.)

2010-05-01 - 2014-02-28

Phase II/III

Terminated17

ICD-10N18.4

Chronic kidney disease, stage 4 (severe)

ICD-10N18.5

Chronic kidney disease, stage 5

ICD-10N18.6

End stage renal disease

ICD-10N18.9

Chronic kidney disease, unspecified

ICD-9585

Chronic renal failure

  • Trial Applicant

    PAREXEL INTERNATIONAL CO., LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 徐國雄 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 周康茹 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator I-WEN WU Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Kwan-Dun Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-Chun CHEN Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 楊五常 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Jin-Bor Chen Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 陳漢湘 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chiu-Ching Huang Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 甘偉志 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 楊郁 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 黃忠餘 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 洪士元 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 楊豐榮 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 王家良 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chen-Chieh Hung Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 陳漢湘 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    約200 participants

  • Global

    750 participants